Illumina stock forecast.

Illumina’s revenue growth of 49.2% over the last twelve months is much better than 11.9% for Thermo Fisher Scientific. However, if we look at a longer time frame, Illumina’s sales grew at an ...7 Jul 2023 ... Illumina stock (NASDAQ NDAQ +0.2% : ILMN) currently trades at $187 per share, roughly 51% below its level in March 2021, and it can see ...Nov 4, 2018 · Illumina generated revenue of $2.75 billion last year, and the company is on track to make around $3.3 billion in 2018. Within the next 10 years, Illumina's market should be much bigger. It doesn ... Illumina's future is looking a bit dim at the moment. Illumina 's ( ILMN -0.92%) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and ...

Headquartered in San Diego, California, Illumina, Inc. (NASDAQ:ILMN) is a life science tools and integrated systems manufacturer. On August 17, 2023, Illumina, Inc. (NASDAQ:ILMN) stock closed at ...Feb 8, 2023 · For the year, Illumina expects core sales to climb 6%-9% and for Grail revenue to be in the range of $90 million to $110 million. ILMN stock analysts called for $4.97 billion in sales, which would ...

See the latest Illumina Inc stock price (ILMN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus rating of Hold and a price target of $217.47, up 99.1% from its current price of $109.22. See the latest news, analysis, and earnings reports for Illumina on MarketBeat.The global next generation sequencing market size was estimated at USD 8.29 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 21.12% from 2024 to 2030. Next Generation Sequencing (NGS) refers to the huge DNA sequencing methods that aid in genomic discovery. Following the World Health Organization's (WHO ...Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis.Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business.

THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 2023. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) …

The Illumina stock prediction results are shown below and presented as a graph, table and text information. Illumina stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Illumina analysts is $ 186.44. Today 200 Day Moving Average is the resistance level (183.87 $).🚀 Illumina stock price forecast: $225; Market Cap: 16.91B, Enterprise value: N/A, P/E: -8.16, PEG ratio: 0.01, EPS: -26.66, Revenue: 4.46B, EBITDA: 3.93B, Income ...Best genomics stocks of 2023. Data source: The Motley Fool. Data current as of June 14, 2023. Genomics Company. Market Capitalization. Description. Illumina ( NASDAQ:ILMN ) $32.4 billion. Industry ...The Illumina stock prediction results are shown below and presented as a graph, table and text information. Illumina stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Illumina analysts is $ 131.5. Today 200 Day Moving Average is the resistance level (178.12 $).Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business.Oct 26, 2023 · Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2026 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 0.59%, beckoning investors to consider amplifying their portfolios. Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: According to 11 analyst offering 12-month price targets in the last 3 months, Illumina has an average ...

ILMN stock recorded green days with 11.39% price volatility over the last 30 days. Based on our Illumina stock forecast, it's now a good time to buy ILMN stock because it's trading 7.84% below our forecast. The Illumina stock prediction for 2025 is currently $ 138.18 increase in the ILMN stock price. In 2030, the Illumina stock will reach $ 343 ... Oct 26, 2023 · Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2024 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 1.6%, beckoning investors to consider amplifying their portfolios. Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Jul 10, 2023 · July 10, 2023 — 12:15 am EDT. Illumina stock (NASDAQ: ILMN) currently trades at $187 per share, roughly 51% below its level in March 2021, and it can see solid returns over time. ILMN saw its ... Illumina Inc Stock Forecast, Predictions & Price Target Add to Watchlist Overview Forecast Earnings Dividend Ownership Analyst price target for ILMN All Analysts Top …

On June 11, the gene sequencing giant Illumina ( ILMN 3.87%) announced that its CEO, Francis deSouza, resigned after a tenure of roughly 10 years and that the company would start looking for a ...

Illumina generated revenue of $2.75 billion last year, and the company is on track to make around $3.3 billion in 2018. Within the next 10 years, Illumina's market should be much bigger. It doesn ...Feb 8, 2023 · For the year, Illumina expects core sales to climb 6%-9% and for Grail revenue to be in the range of $90 million to $110 million. ILMN stock analysts called for $4.97 billion in sales, which would ... Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 4,594.63 (+0.59%) ... Stocks continued to rally as investors shrugged off a cautious retail outlook, but the rally's breadth remains limited to specific stocks and sectors. December 1, 2023 | …Jul 11, 2023 · Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57. ILMN | Complete Illumina Inc. stock news by MarketWatch. ... Illumina Shares Drop on Forecast for 2023 Sales Decline, Wider Loss Nov. 10, 2023 at 8:56 a.m. ET. Stocks to …Illumina’s stock on track for lowest close in 10 years after cutting guidance Nov. 10, 2023 at 10:16 a.m. ET by Ciara Linnane Biotech and Pharma Illumina Stock Is the Worst Performer in the S&P 500. Nov 29, 2023 · According to the issued ratings of 17 analysts in the last year, the consensus rating for Illumina stock is Hold based on the current 3 sell ratings, 7 hold ratings and 7 buy ratings for ILMN. The average twelve-month price prediction for Illumina is $194.56 with a high price target of $328.00 and a low price target of $100.00. On today's stock market, Illumina stock surged 2.5% to close at 201.02. Grail's Hang On Illumina Stock The battle to acquire Grail has been an albatross draped over Illumina.Dec 1, 2023 · Find the latest Illumina, Inc. (ILMN) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.

Dec 1, 2023 · Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus rating of Hold and a price target of $217.47, up 99.1% from its current price of $109.22. See the latest news, analysis, and earnings reports for Illumina on MarketBeat.

THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 2023. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) …

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2024 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 1.6%, beckoning investors to consider amplifying their portfolios.businesswire.com - November 10 at 5:10 PM. ILMN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Illumina, Inc. benzinga.com - November 10 at 5:03 PM. These Stocks Are Moving the Most Today: Plug Power, Trade Desk, Illumina, Doximity, Groupon, Hologic, and More.Oct 16, 2023 · In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ... Illumina expects full-year adjusted profit per share to be between $0.75 and $0.90, compared with its prior forecast of $1.25 to $1.50. The outlook reflects a tax expense impact of about $75 million.Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook ...The average price target for Illumina is $135.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $260.00 ,the lowest forecast is $50.00. The average price target represents 32.91% Increase from the current price of $101.57. Grail raked in $20 million in revenue during the three-month period that ended April 2, according to Illumina's first-quarter earnings release.That's up 100% from the $10 million it reported ...New York, United States , Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Global Blood Group Typing Market Size is to Grow from USD 1.78 Billion in 2022 to USD 3.98 Billion by 2032, at a Compound Annual ...In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Find the latest Illumina, Inc. (ILMN) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.

Illumina, Inc.’s ( ILMN) price is currently up 11.05% so far this month. During the month of March, Illumina, Inc.’s stock price has reached a high of $223.09 and a low of $195.23. Over the last year, Illumina, Inc. has hit prices as high as $371.16 and as low as $173.45. Year to date, Illumina, Inc.’s stock is down 41.85%.Illumina Stock Is the Worst Performer in the S&P 500. Grail Isn’t the Only Issue. Illumina stock was falling sharply Friday after the gene-sequencing company slashed its financial forecasts ...In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Illumina shares. Our integrated forecast predicts a peak price of $117.68 in the forthcoming 30 days, indicating the zenith of the stock's potential performance.Instagram:https://instagram. vymi holdingsefandgvanguard 500 index admiral fundtqqw Jun 20, 2023 · On June 11, the gene sequencing giant Illumina ( ILMN 3.87%) announced that its CEO, Francis deSouza, resigned after a tenure of roughly 10 years and that the company would start looking for a ... What happened. Shares of Illumina ( ILMN 5.21%) were sinking 9.5% at 11:33 a.m. ET on Friday. The decline came after the company announced the departure of CFO Sam Samad in a press release issued ... cheapest catastrophic health insurancebest portfolio management courses HSBC Adjusts Price Target on Illumina to $235 From $270 Aug. 14: MT JPMorgan Adjusts Illumina Price Target to $190 From $235, Maintains Neutral Rating Aug. 10: MT Citigroup Adjusts Illumina's Price Target to $150 From $180, Keeps Sell Rating Aug. 10 best small cap fund Key statistics. On Monday, Illumina Inc (ILMN:NSQ) closed at 94.65, 6.35% above its 52-week low of 89.00, set on Nov 10, 2023. Data delayed at least 15 minutes, as of Nov 27 2023 21:00 GMT. Latest Illumina Inc (ILMN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.The company reported $1.63 earnings per share for the quarter, topping the consensus estimate of $1.53 by $0.10. The company earned $21.70 billion during the quarter, compared to analyst estimates of $23.69 billion. Archer-Daniels-Midland had a trailing twelve-month return on equity of 16.63% and a net margin of 4.05%.